Bausch & Lomb (TSX:BLCO) EPS (Basic) : C$-1.30 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb EPS (Basic)?

Bausch & Lomb's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was C$-0.65. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-1.30.

Bausch & Lomb's EPS (Diluted) for the three months ended in Mar. 2024 was C$-0.65. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-1.30.

Bausch & Lomb's EPS without NRI for the three months ended in Mar. 2024 was C$-0.63. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was -1.04.

During the past 3 years, the average EPS without NRI Growth Rate was -89.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Bausch & Lomb's highest 3-Year average EPS without NRI Growth Rate was -36.10% per year. The lowest was -89.20% per year. And the median was -67.10% per year.

Bausch & Lomb EPS (Basic) Historical Data

The historical data trend for Bausch & Lomb's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb EPS (Basic) Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

1.12

-0.06

0.67

0.03

-0.99

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial												-0.36	-0.12	-0.33	-0.20	-0.65

Bausch & Lomb EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Bausch & Lomb's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-348.816	-	0)	/	350.500
	=	-1.00

Bausch & Lomb's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-226.051	-	0)	/	351.100
	=	-0.64

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.30

Bausch & Lomb (TSX:BLCO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bausch & Lomb EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (TSX:BLCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Executives